Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 39 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Ovulation Induction  [Clear All Filters]
2021
Tsiami, A. P., Goulis D. G., Sotiriadis A. I., & Kolibianakis E. M. (2021).  Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis.. Hormones (Athens). 20(3), 449-461.
2019
Bosdou, J. K., Venetis C. A., Tarlatzis B. C., Grimbizis G. F., & Kolibianakis E. M. (2019).  Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis.. Hum Reprod. 34(3), 491-505.
Lainas, G. T., Lainas T. G., Sfontouris I. A., Chatzimeletiou K., Venetis C. A., Bosdou J. K., et al. (2019).  Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?. Hum Reprod. 34(9), 1770-1777.
2018
Lainas, G. T., Lainas T. G., Venetis C. A., Sfontouris I. A., Zorzovilis I. Z., Alexopoulou E., et al. (2018).  Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome.. Ultrasound Obstet Gynecol. 51(1), 126-133.
2016
Venetis, C. A., Kolibianakis E. M., Bosdou J. K., Lainas G. T., Sfontouris I. A., Tarlatzis B. C., et al. (2016).  Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.. Hum Reprod. 31(8), 1859-65.
Mintziori, G., Goulis D. G., & Kolibianakis E. M. (2016).  Thyroid function and IVF outcome: when to investigate and when to intervene?. Curr Opin Obstet Gynecol. 28(3), 191-7.
Bosdou, J. K., Venetis C. A., Dafopoulos K., Zepiridis L., Chatzimeletiou K., Anifandis G., et al. (2016).  Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial.. Hum Reprod. 31(5), 977-85.
2015
Kolibianakis, E. M., Venetis C. A., Bosdou J. K., Zepiridis L., Chatzimeletiou K., Makedos A., et al. (2015).  Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.. Hum Reprod. 30(2), 432-40.
Sfontouris, I. A., Kolibianakis E. M., Lainas G. T., Navaratnarajah R., Tarlatzis B. C., & Lainas T. G. (2015).  Live birth rates using conventional in vitro fertilization compared to intracytoplasmic sperm injection in Bologna poor responders with a single oocyte retrieved.. J Assist Reprod Genet. 32(5), 691-7.
2014
Ganidou, M. A., Kolibianakis E. M., Venetis C. A., Gerou S., Makedos G. A., Klearchou N., et al. (2014).  Is assessment of anti-Müllerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study.. Gynecol Endocrinol. 30(11), 817-21.
Tsakos, E., Tolikas A., Daniilidis A., & Asimakopoulos B. (2014).  Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.. Arch Gynecol Obstet. 290(6), 1249-53.
Lehert, P., Kolibianakis E. M., Venetis C. A., Schertz J., Saunders H., Arriagada P., et al. (2014).  Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.. Reprod Biol Endocrinol. 12, 17.
Griesinger, G., Mannaerts B., Andersen C. Yding, Witjes H., Kolibianakis E. M., & Gordon K. (2014).  Reply of the authors.. Fertil Steril. 101(1), e5-6.
2013
Fatemi, H. M., Polyzos N. P., van Vaerenbergh I., Bourgain C., Blockeel C., Alsbjerg B., et al. (2013).  Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.. Fertil Steril. 100(3), 742-7.
Prapas, Y., Petousis S., Dagklis T., Panagiotidis Y., Papatheodorou A., Assunta I., et al. (2013).  GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial.. Eur J Obstet Gynecol Reprod Biol. 166(1), 43-6.
Humaidan, P., Polyzos N. P., Alsbjerg B., Erb K., Mikkelsen A. L., Elbaek H. O., et al. (2013).  GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.. Hum Reprod. 28(9), 2511-21.
Panidis, D., Tziomalos K., Papadakis E., Kandaraki E. A., & Katsikis I. (2013).  The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require r. Hormones (Athens). 12(2), 192-200.
Lainas, G. T., Kolibianakis E. M., Sfontouris I. A., Zorzovilis I. Z., Petsas G. K., Lainas T. G., et al. (2013).  Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.. Hum Reprod. 28(7), 1929-42.
Venetis, C. A., Kolibianakis E. M., Bosdou J. K., & Tarlatzis B. C. (2013).  Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles.. Hum Reprod Update. 19(5), 433-57.
Griesinger, G., Mannaerts B., Andersen C. Yding, Witjes H., Kolibianakis E. M., & Gordon K. (2013).  Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials.. Fertil Steril. 100(6), 1622-8.e1-3.
2012
Griesinger, G., & Kolibianakis E. M. (2012).  Can oestradiol pretreatment be used to reliably avoid weekend oocyte retrievals?. Reprod Biomed Online. 24(5), 487-9.
Al-Azemi, M., Kyrou D., Kolibianakis E. M., Humaidan P., Van Vaerenbergh I., Devroey P., et al. (2012).  Elevated progesterone during ovarian stimulation for IVF.. Reprod Biomed Online. 24(4), 381-8.
Lainas, G. T., Kolibianakis E. M., Sfontouris I. A., Zorzovilis I. Z., Petsas G. K., Tarlatzi T. B., et al. (2012).  Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study.. Reprod Biol Endocrinol. 10, 69.
Kolibianakis, E. M., Venetis C. A., Bontis J., & Tarlatzis B. C. (2012).  Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis.. Curr Pharm Biotechnol. 13(3), 464-70.
Kyrou, D., Kolibianakis E. M., Fatemi H. M., Grimbizis G. F., Theodoridis T. D., Camus M., et al. (2012).  Spontaneous triggering of ovulation versus HCG administration in patients undergoing IUI: a prospective randomized study.. Reprod Biomed Online. 25(3), 278-83.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές